CELLARX
Dead / Abandoned — Abandoned — failure to respond (as of 21 Feb 2024)
What this means for you
This application is over — abandoned 05 Feb 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97792405
- Mark type
- Stylized text
- Filed
- 13 Feb 2023
- Abandoned
- 05 Feb 2024
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical, therapeutic and biopharmaceutical preparations and agents for the treatment of cancer, autoimmune disorders, transplant rejections, inflammatory disease, immunological disorders, metabolic disorders, neurological disorders, genetic disorders, psychiatric disorders, gastroenterological disorders, renal disorders, cardiovascular disorders, dermatological disorders, respiratory disorders
- Class 042 — Scientific and technological services: Research and development of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; research and development of technology in the field of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; drug development and discovery; scientific research in the field of drug discovery and development; biomedical research services; preclinical development of therapeutic products; bioinformatic services for scientific research purposes, namely, collecting and analyzing complex biological data through the use of artificial intelligence; computer assisted molecule design involving the use of artificial intelligence technology; diagnostic and screening services, namely, conducting diagnostic testing and evaluation of molecules developed through artificial intelligence means for the combatting of diseases; scientific research, namely, research and analysis services in the fields of artificial intelligence and machine learning analytics and research relating to drug development; software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development
Owner
- Cellarity, Inc., Somerville, MA, US
Prosecution history
- 21 Feb 2024 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 21 Feb 2024 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 01 Nov 2023 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 01 Nov 2023 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 03 Aug 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 03 Aug 2023 — NON-FINAL ACTION E-MAILED
- 03 Aug 2023 — NON-FINAL ACTION WRITTEN
- 21 Jul 2023 — ASSIGNED TO EXAMINER
- 02 Mar 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 16 Feb 2023 — NEW APPLICATION ENTERED